Mitochondrial dysfunction has been recently proposed as a key pathophysiological mechanism [3] linked to processes commonly found in depression, including neurotoxicity, impaired neuroplasticity, inflammation and insulin resistance [2,3,4,5]
From my perspective, Peak Wellness is a strong option for starting GLP-1s responsibly without locking yourself into a complex system
In France, the semaglutide 2.4-mg (Wegovy) was part of an early-access initiative from July 2022 to September 2023
Upon receptor binding, MT1 triggers the cAMP signaling cascade, upregulating the enzyme tyrosinase and increasing the production of eumelanin the dark, UV-protective form of melanin
Figure 4 3.6 Association between GLP-1RA exposure and any substance use disorder Exposure to GLP-1 RA was associated with significantly lower odds of developing any substance use disorder